Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Jarushka Naidoo
Oct 11, 2024, 17:58 | Insight
Jarushka Naidoo: Randomized Phase II Trial Osimertinib with or without Ramucirumab in 1st line EGFR+NSCLC
Jarushka Naidoo shared a post on X: "RAMOSE: Randomized Ph II Trial Osimertinib+/-Ramucirumab in 1L EGFR+…
Oct 11, 2024, 16:32 | Blog
Jarushka Naidoo: Patient Enrollment to Industry vs Federally-funded Cancer Clinical Trials
Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…
Oct 8, 2024, 15:29 | Insight
Jarushka Naidoo: Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab in NSCLC
Jarushka Naidoo shared a post on X: “Long-Term Outcomes 1L Ipilimumab/Nivolumab/-Chemo v Chemo in PDL1<1%…
Sep 26, 2024, 15:35 | Blog
Jarushka Naidoo: TL01 Phase III Datopotamab-Deruxtecan vs Docetaxel in second-line NSCLC
Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…
Sep 24, 2024, 13:32 | Insight
Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation
Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…
Sep 23, 2024, 23:56 | Blog
Jarushka Naidoo: Pleased to present at the WCLC24 on the use of proteomic signatures to identify immune-related toxicities
Jarushka Naidoo posted on LinkedIn: "I was pleased to present at the International Association for…
Sep 22, 2024, 14:06 | Blog
Jarushka Naidoo: Delighted to present the findings of the LECOMTE-PACIFIC study at ESMO24 Congress
Jarushka Naidoo shared a post on LinkedIn: "Delighted to present the findings of the LECOMTE-PACIFIC…
Sep 18, 2024, 15:02 | Blog
Jarushka Naidoo: We are ESMO
Jarushka Naidoo shared a post on X: "As ESMO24 draws to a close… thanks to ESMO…
Sep 18, 2024, 13:13 | Insight
Jarushka Naidoo: ESMO24 Lung mini-orals
Jarushka Naidoo shared on X: "ESMO24 Lung mini-orals. Randomised phase II trial of inhaled corticosteroids…
Sep 14, 2024, 15:36 | Blog
Jarushka Naidoo: WCLC2024 Poster pride
Jarushka Naidoo shared a post on LinkedIn: "WCLC24 Poster pride! Well done to super fellow David…
All: 128 Posts: 11 - 20
Special Coverage